Driehaus Capital Management LLC Orchard Therapeutics PLC Transaction History

Driehaus Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $102,010 - $168,003	-23,237 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $2.03 Million - $4.19 Million	-461,960 Reduced 95.21%	23,237 $169,000
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $181,817 - $238,812	47,103 Added 10.75%	485,197 $2.1 Million
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $5.77 Million - $12 Million	-1,002,650 Reduced 69.59%	438,094 $2.63 Million
Q1 2020 May 15, 2020	SELL	$5.65 - $15.71 $186,902 - $519,686	-33,080 Reduced 2.24%	1,440,744 $10.8 Million
Q4 2019 Feb 12, 2020	BUY	$10.15 - $15.58 $129,645 - $199,003	12,773 Added 0.87%	1,473,824 $20.3 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $376,358 - $529,689	31,680 Added 2.22%	1,461,051 $17.4 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $7.43 Million - $11.6 Million	563,230 Added 65.03%	1,429,371 $20 Million
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $110,071 - $178,625	9,165 Added 1.07%	866,141 $15.5 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $10.6 Million - $16 Million	856,976 New	856,976 $13.5 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.